Lymphotrophic Nanoparticle-enhanced Magnetic Resonance Imaging for Nodal Clinical Target Volume Delineation in the Radiotherapy Treatment Planning of Pelvic Malignancies: Derivation of a Class Solution Nodal Clinical Target Volume

Dextran-coated ultra-small, superparamagnetic, iron oxide particles (USPIO) have been proposed as magnetic resonance (MR) lymph node contrast agents. This thesis analyzed the topographic distributions of the pelvic and inguinal lymph nodes and quantified their spatial relations with the adjacent vas...

Full description

Bibliographic Details
Main Author: Dinniwell, Robert
Other Authors: Milosevic, Michael
Language:en_ca
Published: 2010
Subjects:
Online Access:http://hdl.handle.net/1807/30115
id ndltd-LACETR-oai-collectionscanada.gc.ca-OTU.1807-30115
record_format oai_dc
spelling ndltd-LACETR-oai-collectionscanada.gc.ca-OTU.1807-301152013-04-20T05:21:42ZLymphotrophic Nanoparticle-enhanced Magnetic Resonance Imaging for Nodal Clinical Target Volume Delineation in the Radiotherapy Treatment Planning of Pelvic Malignancies: Derivation of a Class Solution Nodal Clinical Target VolumeDinniwell, RobertUSPIOferumoxtran-10radiotherapyclinical target volumelymph nodeLymphotrophic nanoparticle-enhanced magnetic resonance imaging09920287Dextran-coated ultra-small, superparamagnetic, iron oxide particles (USPIO) have been proposed as magnetic resonance (MR) lymph node contrast agents. This thesis analyzed the topographic distributions of the pelvic and inguinal lymph nodes and quantified their spatial relations with the adjacent vascular system. We hypothesized that USPIO would facilitate identification of normal lymph nodes in a manner superior to that afforded by computed tomography or unenhanced MR, but using current clinically available scanners would be unlikely to identify microscopic nodal metastases. We have constructed a high quality nodal atlas describing probability distributions for lymph node number, size and position. Using this model, we then defined a generic three-dimensional nodal clinical target volume and a means of accurate delineation of this volume in a three-dimensional representation. This is the most quantitative assessment of the pelvic and inguinal lymphatics to date and will help to improve the successful targeting of lymph nodes for radiotherapy.Milosevic, Michael2010-112011-11-30T17:13:36ZWITHHELD_ONE_YEAR2011-11-30T17:13:36Z2011-11-30Thesishttp://hdl.handle.net/1807/30115en_ca
collection NDLTD
language en_ca
sources NDLTD
topic USPIO
ferumoxtran-10
radiotherapy
clinical target volume
lymph node
Lymphotrophic nanoparticle-enhanced magnetic resonance imaging
0992
0287
spellingShingle USPIO
ferumoxtran-10
radiotherapy
clinical target volume
lymph node
Lymphotrophic nanoparticle-enhanced magnetic resonance imaging
0992
0287
Dinniwell, Robert
Lymphotrophic Nanoparticle-enhanced Magnetic Resonance Imaging for Nodal Clinical Target Volume Delineation in the Radiotherapy Treatment Planning of Pelvic Malignancies: Derivation of a Class Solution Nodal Clinical Target Volume
description Dextran-coated ultra-small, superparamagnetic, iron oxide particles (USPIO) have been proposed as magnetic resonance (MR) lymph node contrast agents. This thesis analyzed the topographic distributions of the pelvic and inguinal lymph nodes and quantified their spatial relations with the adjacent vascular system. We hypothesized that USPIO would facilitate identification of normal lymph nodes in a manner superior to that afforded by computed tomography or unenhanced MR, but using current clinically available scanners would be unlikely to identify microscopic nodal metastases. We have constructed a high quality nodal atlas describing probability distributions for lymph node number, size and position. Using this model, we then defined a generic three-dimensional nodal clinical target volume and a means of accurate delineation of this volume in a three-dimensional representation. This is the most quantitative assessment of the pelvic and inguinal lymphatics to date and will help to improve the successful targeting of lymph nodes for radiotherapy.
author2 Milosevic, Michael
author_facet Milosevic, Michael
Dinniwell, Robert
author Dinniwell, Robert
author_sort Dinniwell, Robert
title Lymphotrophic Nanoparticle-enhanced Magnetic Resonance Imaging for Nodal Clinical Target Volume Delineation in the Radiotherapy Treatment Planning of Pelvic Malignancies: Derivation of a Class Solution Nodal Clinical Target Volume
title_short Lymphotrophic Nanoparticle-enhanced Magnetic Resonance Imaging for Nodal Clinical Target Volume Delineation in the Radiotherapy Treatment Planning of Pelvic Malignancies: Derivation of a Class Solution Nodal Clinical Target Volume
title_full Lymphotrophic Nanoparticle-enhanced Magnetic Resonance Imaging for Nodal Clinical Target Volume Delineation in the Radiotherapy Treatment Planning of Pelvic Malignancies: Derivation of a Class Solution Nodal Clinical Target Volume
title_fullStr Lymphotrophic Nanoparticle-enhanced Magnetic Resonance Imaging for Nodal Clinical Target Volume Delineation in the Radiotherapy Treatment Planning of Pelvic Malignancies: Derivation of a Class Solution Nodal Clinical Target Volume
title_full_unstemmed Lymphotrophic Nanoparticle-enhanced Magnetic Resonance Imaging for Nodal Clinical Target Volume Delineation in the Radiotherapy Treatment Planning of Pelvic Malignancies: Derivation of a Class Solution Nodal Clinical Target Volume
title_sort lymphotrophic nanoparticle-enhanced magnetic resonance imaging for nodal clinical target volume delineation in the radiotherapy treatment planning of pelvic malignancies: derivation of a class solution nodal clinical target volume
publishDate 2010
url http://hdl.handle.net/1807/30115
work_keys_str_mv AT dinniwellrobert lymphotrophicnanoparticleenhancedmagneticresonanceimagingfornodalclinicaltargetvolumedelineationintheradiotherapytreatmentplanningofpelvicmalignanciesderivationofaclasssolutionnodalclinicaltargetvolume
_version_ 1716583570588303360